6. パーキンソン病 Parkinson disease Clinical trials / Disease details

臨床試験数 : 2,307 / 薬物数 : 2,007 - (DrugBank : 349) / 標的遺伝子数 : 188 - 標的パスウェイ数 : 199

3 trials found

diseases per page:

Showing 1 to 3 of 3 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2009-011093-15-DE (EUCTR)	16/11/2009	23/09/2009	The role of the neurotransmitters dopamine and acetylcholine in the interaction of selective attenti ...	The role of the neurotransmitters dopamine and acetylcholine in the interaction of selective attenti ...	Healthy volunteers MedDRA version: 12.0;Level: LLT;Classification code 10012271;Term: Dementia Alzhe ...	Trade Name: Nacom INN or Proposed INN: LEVODOPA Other descriptive name: L-Dopa Trade Name: Reminyl INN o ...	Otto-von-Guericke University, Medical Faculty, Dpt. of Neurology	NULL	Not Recruiting			Female: yes Male: yes	80	Phase 2	Germany
2	EUCTR2008-006278-13-NL (EUCTR)	04/02/2009	15/10/2008	Motor function optimization in advanced Parkinson’s disease patients, combined with galantamineto pr ...	Motor function optimization in advanced Parkinson’s disease patients, combined with galantamineto pr ...	patients with advanced (>5 years) Parkinson's disease and visual hallucinations. MedDRA version: 9.1 ...	Trade Name: Reminyl Retard Trade Name: Sinemet 125 mg	UMCG	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	10		Netherlands
3	NCT00211588 (ClinicalTrials.gov)	June 2004	13/9/2005	Galantamine Executive Function in Parkinson's Disease	Investigator Initiated Study: GalantamineCR Potential Enhancement of Attentional and Executive Funct ...	Parkinson's Disease	Drug: galantamine	Memorial Hospital of Rhode Island	Ortho-McNeil Neurologics, Inc.	Active, not recruiting	60 Years	85 Years	Both	90	N/A	United States

First Previous1Next Last